Home › Companies › AVIDITY BIOSCIENCES INC. › 2023-2024

AVIDITY BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and AVIDITY BIOSCIENCES INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated October 13, 2026.

  • 5Ballot items
  • 170Asset managers
  • 1,232Fund votes
  • June 13, 2024Meeting date

Results at a glance

Meeting of June 13, 2024: 5 items on AVIDITY BIOSCIENCES INC.’s Form 8-K, filed June 14, 2024: 2 approved · 3 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AVIDITY BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by AVIDITY BIOSCIENCES INC.

These tallies are AVIDITY BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AVIDITY BIOSCIENCES INC. — official shareholder meeting results, meeting held June 13, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Carsten Boess 63,891,628---- 9,825,4565,160,086 87%Not verified—
Elect Director: Sarah Boyce 67,562,873---- 6,154,2115,160,086 92%Not verified—
Elect Director: Troy Wilson, Ph.D., J.D. 45,112,985---- 28,048,7385,715,447 62%Not verified—
2. The ratification of the appointment of BDO USA, P.C 78,738,26881,36657,536 --0 99.8%Approved—
3. The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in the proxy statement related to the 2024 Annual Meeting 67,573,742995,2075,179,358 --5,128,863 99%Approved—

Source: AVIDITY BIOSCIENCES INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.

How asset managers voted at the AVIDITY BIOSCIENCES INC. 2023-2024 meeting

Each item below shows how the 170 asset managers that disclosed a AVIDITY BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Carsten Boess

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 63,891,628WITHHELD: 9,825,456
Details: description as filed, official tally, votes by 62 asset managers

Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Carsten Boess

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Carsten Boess”): 63,891,628 for, 9,825,456 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 62 asset managers below reported 28,594,691 for, 3,878,992 withheld.

FOR
FOR: 28,594,691WITHHOLD: 3,878,992
Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity11,131,3040 035,878For
T. Rowe Price7,920,3390 00For
Vanguard3,766,9890 00For
BlackRock00 01,622,447Withhold
Artisan1,457,8940 00For
State Street1,349,9050 017,971For
TIAA1,074,2050 00For
Charles Schwab550,0760 00For
Dimensional00 0538,602Withhold
OLD WESTBURY FUNDS INC00 0314,734Withhold
Equitable37,0310 0198,930Mixed
JPMorgan203,2470 00For
Brighthouse182,1490 019,645Mixed
Direxion Shares ETF Trust00 0180,994Withhold
Global X164,1850 00For
John Hancock131,7000 027,347Mixed
Hartford158,6970 00For
American Century00 0156,967Withhold
QUANTITATIVE MASTER SERIES LLC00 0137,879Withhold
MoA Funds Corp00 0136,191Withhold
Aberdeen00 0129,414Withhold
AIG/SunAmerica00 0101,815Withhold
Prudential/PGIM69,1670 00For
Transamerica68,7280 00For
Lincoln Financial61,4000 06,406Mixed

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

2. Elect Director: Troy Wilson, Ph.D., J.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%WITHHELD
FOR: 45,112,985WITHHELD: 28,048,738
Details: description as filed, official tally, votes by 62 asset managers

Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Dr. Troy Wilson

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Troy Wilson, Ph.D., J.D.”): 45,112,985 for, 28,048,738 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 62% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 62 asset managers below reported 14,317,378 for, 18,156,305 withheld.

FORWITHHOLD
FOR: 14,317,378WITHHOLD: 18,156,305
Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity11,131,3040 035,878For
T. Rowe Price00 07,920,339Withhold
Vanguard00 03,766,989Withhold
BlackRock00 01,622,447Withhold
Artisan1,457,8940 00For
State Street13,2330 01,354,643Withhold
TIAA1,074,2050 00For
Charles Schwab00 0550,076Withhold
Dimensional00 0538,602Withhold
OLD WESTBURY FUNDS INC00 0314,734Withhold
Equitable00 0235,961Withhold
JPMorgan203,2470 00For
Brighthouse58,2460 0143,548Mixed
Direxion Shares ETF Trust00 0180,994Withhold
Global X00 0164,185Withhold
John Hancock22,6820 0136,365Mixed
Hartford158,6970 00For
American Century00 0156,967Withhold
QUANTITATIVE MASTER SERIES LLC00 0137,879Withhold
MoA Funds Corp00 0136,191Withhold
Aberdeen00 0129,414Withhold
AIG/SunAmerica00 0101,815Withhold
Prudential/PGIM46,0010 023,166Mixed
Transamerica00 068,728Withhold
Lincoln Financial00 067,806Withhold

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

3. Elect Director: Sarah Boyce

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 67,562,873WITHHELD: 6,154,211
Details: description as filed, official tally, votes by 62 asset managers

Description as filed by funds: To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Sarah Boyce

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sarah Boyce”): 67,562,873 for, 6,154,211 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 62 asset managers below reported 30,792,173 for, 1,681,510 withheld.

FOR
FOR: 30,792,173WITHHOLD: 1,681,510
Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity11,167,1820 00For
T. Rowe Price7,920,3390 00For
Vanguard3,766,9890 00For
BlackRock1,622,4470 00For
Artisan1,457,8940 00For
State Street1,349,9050 017,971For
TIAA1,074,2050 00For
Charles Schwab550,0760 00For
Dimensional00 0538,602Withhold
OLD WESTBURY FUNDS INC00 0314,734Withhold
Equitable235,9610 00For
JPMorgan203,2470 00For
Brighthouse182,1490 019,645Mixed
Direxion Shares ETF Trust00 0180,994Withhold
Global X164,1850 00For
John Hancock131,7000 027,347Mixed
Hartford158,6970 00For
American Century00 0156,967Withhold
QUANTITATIVE MASTER SERIES LLC137,8790 00For
MoA Funds Corp00 0136,191Withhold
Aberdeen129,4140 00For
AIG/SunAmerica00 0101,815Withhold
Prudential/PGIM69,1670 00For
Transamerica68,7280 00For
Lincoln Financial61,4000 06,406Mixed

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

4. 3. The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 67,573,742AGAINST: 995,207
Details: description as filed, official tally, votes by 170 asset managers

Description as filed by funds: To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in the related proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and

AVIDITY BIOSCIENCES INC.’s own tally for this item (“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in the proxy statement related to the 2024 Annual Meeting”): 67,573,742 for, 995,207 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 63 asset managers voting on “To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity11,167,1820 00For
T. Rowe Price7,920,3390 00For
Vanguard3,766,9890 00For
Artisan3,318,8300 00For
BlackRock1,622,4470 00For
State Street1,362,8355,041 00For
TIAA1,074,2050 00For
Charles Schwab550,0760 00For
Dimensional538,6020 00For
OLD WESTBURY FUNDS INC314,7340 00For
Equitable235,9610 00For
JPMorgan203,2470 00For
Brighthouse201,7940 00For
Direxion Shares ETF Trust180,9940 00For
Global X164,1850 00For
John Hancock159,0470 00For
Hartford158,6970 00For
American Century0156,967 00Against
QUANTITATIVE MASTER SERIES LLC137,8790 00For
MoA Funds Corp136,1910 00For
Aberdeen129,4140 00For
Simplify Exchange Traded Funds125,0000 00For
AIG/SunAmerica101,8150 00For
Prudential/PGIM69,1670 00For
Transamerica68,7280 00For

Fund voting reports, all 63 managers: 34,270,508 for, 189,111 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 125 asset managers voting on “To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity14,070,6830 00For
T. Rowe Price9,911,4970 00For
RTW INVESTMENTS, LP6,746,8750 00For
RA CAPITAL MANAGEMENT, L.P.3,464,7450 00For
Avoro Capital Advisors LLC3,000,0000 00For
State Street2,512,04827,621 00For
BlackRock1,741,60927,520 00For
GEODE CAPITAL MANAGEMENT, LLC1,524,5220 00For
Wellington1,138,0340 00For
Nuveen1,077,3230 00For
JPMorgan781,5310 00For
Woodline Partners LP685,6660 00For
5AM Venture Management, LLC665,5550 00For
Northern Trust579,4043,450 00For
Charles Schwab550,0760 00For
ORBIMED ADVISORS LLC372,8860 00For
BESSEMER INVESTMENT MANAGEMENT LLC314,7340 00For
SILVERARC CAPITAL MANAGEMENT, LLC271,4640 00For
Rafferty Asset Management, LLC180,9940 00For
PNC BANK, NATIONAL ASSOCIATION158,0540 00For
American Century0156,967 00Against
Dimensional152,6570 00For
Janus Henderson147,5080 00For
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC141,8360 00For
Aberdeen129,4140 00For

Institutional-manager reports, all 125 managers: 51,736,429 for, 641,985 against, 47,057 withheld, 3,776 abstained, 4,462 not voted. Showing the 25 largest; see all in the interactive database.

5. 2. The ratification of the appointment of BDO USA, P.C

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 78,738,268AGAINST: 81,366
Details: description as filed, official tally, votes by 62 asset managers

Description as filed by funds: To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

AVIDITY BIOSCIENCES INC.’s own tally for this item (“2. The ratification of the appointment of BDO USA, P.C”): 78,738,268 for, 81,366 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment was ratified by the votes indicated:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 62 asset managers below reported 32,471,599 for, 2,084 against.

FOR
FOR: 32,471,599AGAINST: 2,084
Largest asset managers voting on “To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity11,167,1820 00For
T. Rowe Price7,920,3390 00For
Vanguard3,766,9890 00For
BlackRock1,622,4470 00For
Artisan1,457,8940 00For
State Street1,365,7922,084 00For
TIAA1,074,2050 00For
Charles Schwab550,0760 00For
Dimensional538,6020 00For
OLD WESTBURY FUNDS INC314,7340 00For
Equitable235,9610 00For
JPMorgan203,2470 00For
Brighthouse201,7940 00For
Direxion Shares ETF Trust180,9940 00For
Global X164,1850 00For
John Hancock159,0470 00For
Hartford158,6970 00For
American Century156,9670 00For
QUANTITATIVE MASTER SERIES LLC137,8790 00For
MoA Funds Corp136,1910 00For
Aberdeen129,4140 00For
AIG/SunAmerica101,8150 00For
Prudential/PGIM69,1670 00For
Transamerica68,7280 00For
Lincoln Financial67,8060 00For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

Largest AVIDITY BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 95,594,000 shares outstanding at the time of that meeting.

Fund voting reports: top AVIDITY BIOSCIENCES INC. shareholders by shares voted on “To consider and vote upon, on an advisory basis, the compensation of our named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 11.68%
2T. Rowe Price 8.29%
3Vanguard 3.94%
4Artisan 3.47%
5BlackRock 1.70%
6State Street 1.43%
7TIAA 1.12%
8Charles Schwab 0.58%
9Dimensional 0.56%
10OLD WESTBURY FUNDS INC 0.33%
Institutional-manager reports: top AVIDITY BIOSCIENCES INC. shareholders by shares voted on “To consider and vote upon, on an advisory basis, the compensation of our named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 14.72%
2T. Rowe Price 10.37%
3RTW INVESTMENTS, LP 7.06%
4RA CAPITAL MANAGEMENT, L.P. 3.62%
5Avoro Capital Advisors LLC 3.14%
6State Street 2.66%
7BlackRock 1.85%
8GEODE CAPITAL MANAGEMENT, LLC 1.59%
9Wellington 1.19%
10Nuveen 1.13%

Reported AVIDITY BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AVIDITY BIOSCIENCES INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
FMR (Fidelity) 22.58% 13F
Vanguard Group 13.83% 13F
FMR LLC 13.10% DEF14A
Entities affiliated with T. Rowe Price Associates, Inc. 10.10% DEF14A
Entities affiliated with RTW Investments 9.99% DEF14A
BlackRock 9.63% 13F
Entities affiliated with Avoro Capital Advisors LLC 8.97% DEF14A
T. Rowe Price 7.77% 13F
Cowen Financial Products LLC 5.89% 13G
Bristol-Myers Squibb Company 5.31% DEF14A

Percentages above are of 95,594,000 shares outstanding, as reported by AVIDITY BIOSCIENCES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AVIDITY BIOSCIENCES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.

At AVIDITY BIOSCIENCES INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 170 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,232 separate fund positions. On the most widely held item on that ballot — To consider and vote upon, on an advisory basis, the compensation of our named executive… — AVIDITY BIOSCIENCES INC.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AVIDITY BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.

AVIDITY BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.